Shreeram Aradhye has been appointed executive vice president and chief development officer of Axcella Health. Aradhye was most recently chief medical officer and global head of medical affairs for Novartis (NYSE: [[ticker:NVS]]). Cambridge, MA-based Axcella is developing drugs intended to regulate human metabolism. The company has early-stage programs addressing liver and muscular disorders.
Author: Frank Vinluan
Xconomy Editor Frank Vinluan is a business journalist with experience covering technology and life sciences. Based in Raleigh, he was a staff writer at the Triangle Business Journal covering technology, biotechnology and energy before joining MedCityNews.com as North Carolina bureau chief. Prior to moving to North Carolina’s Research Triangle in 2007 he held business reporting positions at The Des Moines Register and The Seattle Times.
View all posts by Frank Vinluan
